Innovative Technique Identifies Oxidation Forms in Monoclonal Antibodies
A new method has been developed to detect previously unrecognized oxidation forms in monoclonal antibodies, which could significantly influence their stability and therapeutic efficacy.
Monoclonal antibodies are essential biologic medicines used in the treatment of various conditions, including cancer and autoimmune diseases. Their effectiveness is closely tied to their structural integrity.
Oxidation can occur during the manufacturing process, as well as during storage and transport, potentially compromising the quality of these drugs. Understanding these changes is critical for maintaining drug efficacy.
The newly introduced method enhances the detection of these oxidation forms, providing insights into antibody stability and potentially guiding improvements in manufacturing practices.